FMR »

Mineralys Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by FMR from 13F filings

Historical chart of FMR investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2023-09-30 $11M 1.2M 9.51
2023-06-30 $13M 731k 17.05
2023-03-31 $9.9k 629 15.66

More positions owned by FMR

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Netflix (NFLX)
Mastercard Incorporated Cl A (MA)
Regeneron Pharmaceuticals (REGN)

View all positions for FMR

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments
Walleye Trading Advisors

View all funds holding Mineralys Therapeutics